Trial intelligence / Profile preview

High-dose nasal steroid spray after surgery for nasal polyps

TCTR20211225001Phase 4Recruiting

Sponsor
Sirinkarn Sookdee
Start
Nov 2021
Countries
1
01

Overview

Phase 4, randomised trial in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Sirinkarn Sookdee. Primary endpoint: Postoperative nasal polyp control. Started Nov 2021; status: recruiting.

02

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on TCTR20211225001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20211225001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call